Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 3
Blood pressure and WC (cm ± SD, adjusted for age, gender).
| | Total
() | Northern Europe
() | Southern Europe
() | North America
() | Middle East
() | Asia
() | value |
| | SBP (mmHg) | | | | | | | | | <120 | 97.5 (0.557) | 100.2 (1.028) | 98.5 (0.948) | 100.9 (1.254) | 96.9 (3.078) | 89.9 (0.994) | <0.0001 | | 120–139 | 98.5 (0.218) | 100.3 (0.400) | 99.2 (0.314) | 102.1 (0.600) | 100.8 (1.536) | 90.6 (0.445) | <0.0001 | | 140–159 | 99.6 (0.171) | 102.2 (0.268) | 100.3 (0.255) | 102.5 (0.548) | 101.0 (0.923) | 89.0 (0.392) | <0.0001 | | 160–179 | 100.9 (0.244) | 103.4 (0.373) | 102.0 (0.364) | 102.4 (0.880) | 102.4 (1.070) | 89.0 (0.634) | <0.0001 | | ≥180 | 101.2 (0.414) | 103.3 (0.603) | 103.4 (0.642) | 101.3 (1.816) | 104.6 (1.528) | 89.2 (1.067) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.1275 | <0.0001 | | | DBP (mmHg) | | | | | | | | | <90 | 98.8 (0.154) | 101.1 (0.256) | 99.5 (0.237) | 101.7 (0.405) | 100.1 (1.024) | 89.9 (0.334) | <0.0001 | | 90–99 | 100.1 (0.198) | 103.1 (0.309) | 100.5 (0.287) | 102.5 (0.782) | 100.4 (0.924) | 89.0 (0.476) | <0.0001 | | 100–109 | 101.3 (0.305) | 102.8 (0.485) | 103.4 (0.441) | 105.1 (1.417) | 105.6 (1.230) | 89.5 (0.716) | <0.0001 | | ≥110 | 103.2 (0.607) | 105.1 (0.916) | 104.1 (0.891) | 107.4 (3.250) | 105.0 (2.041) | 89.7 (1.611) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0012 | <0.0001 | | | RR (mmHg) | | | | | | | | | uncontrolled* | 100.7 (0.167) | 102.7 (0.201) | 101.2 (0.195) | 102.2 (0.445) | 102.1 (0.619) | 89.2 (0.311) | <0.0001 | | controlled** | 98.8 (0.149) | 100.1 (0.400) | 99.0 (0.315) | 102.1 (0.559) | 100.0 (1.523) | 90.2 (0.430) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0882 | <0.0001 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|
